Академический Документы
Профессиональный Документы
Культура Документы
Purpose of review
Flexor tendon injuries of the hand continue to be a
challenging problem. This is a review of the latest advances
in flexor tendon injuries and their treatment.
Recent findings
Advances have been in two major areas: flexor tendon repair
technique and biological advances. Bone suture-anchor
repair methods for zone I flexor tendon injuries have shown
increased strength, decreased gapping, and the avoidance
of button complications. For zone II injuries, a new
combination repair method of a cross-locked cruciate core
suture and interlocking horizontal mattress circumferential
suture has superior strength with minimal increase in work
of flexion. The major areas of biological research are cellular
research and tissue engineering, molecular medicine, gene
therapy, and pulsed electromagnetic field therapy.
Summary
New flexor tendon repair methods have the advantage of
increased strength to allow for early active range of motion
with minimal gapping and minimal increase in work of flexion
to allow for smooth tendon gliding. Advances in biological
medicine may augment tendon repair strength while
decreasing adhesions.
Keywords
flexor tendon repair, hand, molecular medicine, tissue
engineering
Curr Opin Orthop 18:339346. 2007 Lippincott Williams & Wilkins.
NYU Hospital for Joint Diseases Orthopaedic Institute, New York, New York, USA
Correspondence to Steve K. Lee, MD, NYU Hospital for Joint Diseases
Orthopaedic Institute, 301 East 17th Street, Suite 413, New York, NY 10003, USA
Tel: +1 212 598 6697; fax: +1 212 598 6560; e-mail: Steve.Lee@nyumc.org
Current Opinion in Orthopaedics 2007, 18:339346
Abbreviation
bFGF
Introduction
In the past 50 years there have been significant advances
in the treatment of flexor tendon injuries. Until the 1960s,
Bunnells [1] concept of no mans land was universally
accepted and reconstruction of zone II flexor tendon
injuries with tendon grafts was performed rather than
primary repair. During the 1960s, several reports by
authors such as Verdan [2,3], Kleinert et al. [4] and Kessler
and Nissim [5] refuted the concept that zone II flexor
tendon injuries should not be repaired primarily. The
current flexor tendon injury areas of interest include
methods of repair and the use of biological science to
improve the outcomes of the treatment of flexor
tendon injury.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Figure 2 (a) Volar and (b) lateral views showing avulsed flexor
digitorum profundus (FDP) tendon and surgical exposure, and
(c) volar and cross-sectional views showing suture-anchor
placement in the distal phalanx and suture technique
From [6].
Originally called no-mans land by Bunnell, flexor tendon repair in zone II is now commonplace, although the
ability to achieve predictably excellent results remains
elusive. Recent research is in the areas of repair method
and materials and adhesion reduction.
Repair method and materials
From [13].
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
square half-hitches). Based on these studies, we recommend six knots of 3-0 Fiberwire as the preferable
core suture.
For the circumferential suture, Dona et al. [26] studied
four groups: running, cross stitch (Silfverskiold), interlocking cross stitch, and interlocking horizontal mattress
in a sheep model with 6-0 Prolene and no core suture.
The interlocking horizontal mattress method had the
highest 2 mm gap force (26 N), stiffness, and ultimate
load to failure (53 N) [26] (Fig. 5).
Lee et al. [35] reported the superior biomechanical
characteristics of the cross-locked cruciateinterlocking
horizontal mattress (CLCIHM) combination repair and
we recently have confirmed superior strength (90 N 2 mm
gap force, 111 N load to failure) and low work of flexion
characteristics (5% increase in work of flexion; Goldstein
RY, Geldwert D, Terranova C et al., unpublished data) in
a cadaveric cyclically loading model (Fig. 6). We have had
early clinical success and this remains our repair method
of choice for zone II injuries (Figs 7 and 8).
Adhesions
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Biological advances
Manipulation of biological aspects of tendon healing has
the potential to diminish the rate of adhesion formation
and increase the strength of the repair. Biological research
of tendon repair has taken place at the cellular, molecular
and genetic levels. Cellular research has focused on
mesenchymal stem cells and tissue engineering [43].
Mesenchymal stem cells are pluripotential cells that have
the ability to differentiate into various types of cells
including myocytes, chondrocytes, and tendon fibroblasts
[44]. Mesenchymal stem cells also produce extracellular
matrix and growth factors needed for tendon healing [43].
Tissue engineering is the process by which new tissues
are created in an ex-vivo environment. Efforts in tissue
engineering have focused on the use of scaffolds that
allow cells to grow that are easy to obtain, elicit minimal
immunogenic response, and are easily modulated by
local environmental factors [45]. Molecular medical
approaches to improved tendon healing concentrate on
the growth factors, cytokines, and extracellular matrix
molecules that are involved in such processes as proteoglycan synthesis, blood vessel growth, and cell proliferation [43]. Gene therapy is the process by which newly
engineered genes are introduced into a host animal.
Molecular medicine
Tendon strength after repair can be influenced by molecular medicine. Hamada et al. [53] conducted an in-vivo
rabbit study in which flexor tendon lacerations were
repaired with either plain nylon sutures or nylon sutures
coated with basic fibroblast growth factor (bFGF). The
results of this study showed that lacerations repaired with
the bFGF coated nylon sutures had a higher ultimate
strength and a greater fibroblastic response than lacerations repaired with plain nylon sutures. The use of growth
factors or modalities that augment production of such
factors has the potential to significantly increase the
strength of flexor tendon repairs.
Costa et al. [54] conducted research to determine the
effect of individual growth factors (platelet-derived
growth factor-BB, insulin-like growth factor-1, and basic
fibroblast growth factor) on in-vitro growth of rabbit
flexor tendon synovial sheath cells, epitenon cells, and
endotenon cells. The results of this study showed that
proliferation of all cells increased in the presence of
individual growth factors and that there was a synergistic
effect of cell proliferation when these growth factors were
combined.
Control of adhesion formation through molecular medicine could significantly improve outcomes. McCombe
et al. [55] reported on the results of use of an orally
administered collagen synthesis inhibitor (CPHI-I)
in a rat model with a crush injury of a flexor tendon.
They showed a significantly decreased work of flexion
(P < 0.05) in the treatment groups that received CPHI-I.
The rate of dermal collagen synthesis was also reduced
in the treatment group but did not have an impact on
wound healing.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Gene therapy
Gene therapy aims to treat disorders by the introduction
of engineered genes that code for proteins that are absent
or not normally produced by the host. There are several
vectors that can be used in the delivery of growth factor
genes. Such vectors include adenoviral vectors, adenoassociated viral vectors, and liposome-plasmid vectors.
Zhu et al. [63] compared the histological tissue reactions
in a rabbit model to adenoviral, adeno-associated viral,
and liposome-plasmid vectors with the early healing
responses of injured flexor tendons. Of the three viral
vectors tested, it appears that the adeno-associated viral
vector is the best vector for gene delivery because it
elicits a minimal adverse response in tendon and it causes
no human diseases [63,6466].
Much can be learned about the roles of various cytokines
and proteins by analyzing gene expression in injured and
healing tendons. Berglund et al. [67] analyzed the RNA
expression of rabbit flexor tendons and flexor tendon
sheaths in various stages of healing. The results of this
study showed that while both flexor tendon and sheath
had increased expression of collagen type III mRNA,
Pulsed-electromagnetic-field therapy
Strauch et al. [68] have demonstrated in a rat Achilles
tendon model that pulsed-electromagnetic-field therapy
configured to enhance Ca2 binding in the growth factor
cascades involved in tissue healing increased the tensile
strength up to 69% compared with control animals. If
similar effects occur in humans, increased strength may
allow for safe early motion with decreased rupture
risk.
Conclusion
We continue to search for the Holy Grail of flexor tendon
repair which will restore function to the hand after these
potentially devastating injuries. A strong repair that does
not gap with early motion and allows for smooth gliding is
a prerequisite for a satisfactory outcome. The use of
biological techniques to maximize healing and strength
and minimize adhesion formation may decrease the need
for complex tenolysis procedures and late flexor tendon
reconstruction. The future of treatment is the marriage of
the scalpel and syringe.
Acknowledgements
We thank Rachel Y. Goldstein, BA, Michael R. Hausman, MD, Karl J.
Jepsen, PhD, Philip Nasser, MS, and Carl Terranova, PhD, for their
contributions to the original research.
Verdan CE. Primary repair of flexor tendons. J Bone Joint Surg [Am] 1960;
42-A:647657.
McCallister WV, Ambrose HC, Katolik LI, Trumble TE. Comparison of pullout
button versus suture anchor for zone I flexor tendon repair. J Hand Surg [Am]
2006; 31:246251.
This study showed that there was no significant difference in clinical outcome after
zone I flexor tendon injury treated with suture anchors or the pullout-button
technique, except that patients treated with a suture anchor returned to work
2.5 weeks earlier than the other group.
6
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Moiemen NS, Elliot D. Primary flexor tendon repair in zone 1. J Hand Surg [Br]
2000; 25:7884.
Latendresse K, Dona E, Scougall PJ, et al. Cyclic testing of pullout sutures and
micro-mitek suture anchors in flexor digitorum profundus tendon distal fixation.
J Hand Surg [Am] 2005; 30:471478.
10 Schreuder FB, Scougall PJ, Puchert E, et al. Effect of suture material on gap
formation and failure in type 1 FDP avulsion repairs in a cadaver model. Clin
Biomech 2006; 21:481484.
This biomechanical study compared gap formation in flexor digitorum profundus
tendon repairs using monofilament polypropylene, braided polyester, and a synthetic polyfilament suture ensheathed by caprolactan and showed that braided
polyester had the lowest gap formation.
11 Silva MJ, Hollstien SB, Brodt MD, et al. Flexor digitorum profundus tendon-tobone repair: an ex vivo biomechanical analysis of 3 pullout suture techniques.
J Hand Surg 1998; 23A:120126.
12 Gelberman RH, Boyer MI, Brodt MD, et al. The effect of gap formation at the
repair site on the strength and excursion of intrasynovial flexor tendons. An
experimental study on the early stages of tendon-healing in dogs. J Bone Joint
Surg [Am] 1999; 81:975982.
13 Zhao C, Amadio PC, Tanaka T, et al. Effect of gap size on gliding resistance
after flexor tendon repair. J Bone Joint Surg [Am] 2004; 86-A:24822488.
14 Schreuder FB, Scougall PJ, Puchert E, et al. The effect of mitek anchor
insertion angle to attachment of FDP avulsion injuries. J Hand Surg [Br] 2006;
31:292295.
This study compared the biomechanical properties of different suture-anchor
orientations (perpendicular to phalanx or 458 retrograde to phalanx compared with
458 antegrade to phalanx) in the treatment of zone I flexor digitorum profundus
injuries. The study showed no difference in load to failure among the three orientations, but the lowest gap formation was seen in the 458 retrograde placement group.
15 Zook EG. Complications of the perionychium. Hand Clin 1986; 2:407427.
16 Zook EG. Anatomy and physiology of the perionychium. Hand Clin 1990;
6:17.
17 Leddy JP, Packer JW. Avulsion of the profundus tendon insertion in athletes.
J Hand Surg 1977; 2:6669.
18 Brustein M, Pellegrini J, Choueka J, et al. Bone suture anchors versus the
pullout button for repair of distal profundus tendon injuries: a comparison of
strength in human cadaveric hands. J Hand Surg 2001; 26A:489496.
19 Burkhart SS. The deadman theory of suture anchors: observations along a
south Texas fence line. Arthroscopy 1995; 11:119123.
20 Osada D, Fujita S, Tamai K, et al. Flexor tendon repair in zone II with 6-strand
techniques and early active mobilization. J Hand Surg [Am] 2006; 31:987
992.
Twenty-six out of 27 (96%) patients had good or excellent results after undergoing
a six-strand suture technique for zone II flexor tendon lacerations followed by active
mobilization.
21 Su BW, Solomons M, Barrow A, et al. Device for zone-II flexor tendon repair.
A multicenter, randomized, blinded, clinical trial. J Bone Joint Surg [Am] 2005;
87:923935.
22 Su BW, Raia FJ, Quitkin HM, et al. Gross and histological analysis of healing
after dog flexor tendon repair with the Teno Fix device. J Hand Surg [Br] 2006;
31:524529.
This study reports on the histological findings of canine flexor tendon repair using
the Teno Fix device. The results showed that the use of the Teno Fix device resulted
in few if any adhesions as well as a smooth gliding surface.
23 Matheson G, Nicklin S, Gianoutsous MP, Walsh WR. Comparison of zone II
flexor tendon repairs using an in vitro linear cyclic testing protocol. Clin
Biomech 2005; 20:718722.
24 Croog A, Goldstein R, Nasser P, Lee SK. Comparative biomechanic performances of locked cruciate four-strand flexor tendon repairs in an ex vivo
porcine model. J Hand Surg [Am] 2007; 32:225232.
25 Lawrence TM, Davis TR. A biomechanical analysis of suture materials and
their influence on a four-strand flexor tendon repair. J Hand Surg [Am] 2005;
30:836841.
26 Dona E, Turner AW, Gianoutsos MP, Walsh WR. Biomechanical properties of
four circumferential flexor tendon suture techniques. J Hand Surg [Am] 2003;
28:824831.
27 Barrie KA, Tomak SL, Cholewicki J, et al. Effect of suture locking and suture
caliber on fatigue strength of flexor tendon repairs. J Hand Surg [Am] 2001;
26:340346.
48 Cao Y, Liu Y, Liu W, et al. Bridging tendon defects using autologous tenocyte
engineered tendon in a hen model. Plast Reconstr Surg 2002; 110:1280
1289.
28 Barrie KA, Tomak SL, Cholewicki J, Wolfe SW. The role of multiple strands
and locking sutures on gap formation of flexor tendon repairs during cyclical
loading. J Hand Surg [Am] 2000; 25:714720.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
59 Zhao C, Sun YL, Amadio PC, et al. Surface treatment of flexor tendon
autografts with carbodiimide-derivatized hyaluronic acid. An in vivo canine
model. J Bone Joint Surg [Am] 2006; 88:21812191.
This study reported that, in a dog model, tendon grafts treated with carbodiimidederivatized hyaluronic acid had significantly lower work of flexion and significantly
lower gliding resistance than controls treated with saline solution.
60 Tanaka T, Sun YL, Zhao C, et al. Optimization of surface modifications of
extrasynovial tendon to improve its gliding ability in a canine model in vitro.
J Orthop Res 2006; 24:15551561.
61 Bates SJ, Morrow E, Zhang AY, et al. Mannose-6-phosphate, an inhibitor of
transforming growth factor-beta, improves range of motion after flexor tendon
repair. J Bone Joint Surg [Am] 2006; 88:24652472.
This study showed that repaired rabbit tendon lacerations treated with a single low
dose of mannose 6-phosphate had significantly better range of motion than the
other treatment groups (control group, decorin treatment group, and high-dose
mannose 6-phosphate group).
62 Sun Y, Berger EJ, Zhao C, et al. Expression and mapping of lubricin in canine
flexor tendon. J Orthop Res 2006; 24:18611868.
This study investigated the distribution of lubricin (boundary lubricant) in a canine
model and demonstrated its presence on the tendon surface and at sites in the
tendon subject to shear force, compression, and tension.
63 Zhu B, Cao Y, Xin KQ, et al. Tissue reactions of adenoviral, adeno-associated
viral, and liposome-plasmid vectors in tendons and comparison with earlystage healing responses of injured flexor tendons. J Hand Surg [Am] 2006;
31:16521660.
This study evaluated the tissue reactions to three different vectors (adenoviral,
adeno-associated viral, and liposome-plasmid) for gene delivery. The lowest
amount of tissue reaction was seen with the adeno-associated viral vector.
64 Schwarz EM. The adeno-associated virus vector for orthopaedic gene
therapy. Clin Orthop Relat Res 2000; 379 (Suppl):S31S39.
65 Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum
antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999;
59:406411.
66 Daly TM. Overview of adeno-associated viral vectors. Methods Mol Biol 2004;
246:157165.
68 Strauch B, Patel MK, Rosen DJ, et al. Pulsed magnetic field therapy increases
tensile strength in a rat Achilles tendon repair model. J Hand Surg [Am] 2006;
31:11311135.
Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.